These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30887881)

  • 21. Proposed trade agreement could increase patent protection for pharmaceuticals.
    Eggertson L
    CMAJ; 2013 Jul; 185(10):E459-60. PubMed ID: 23695601
    [No Abstract]   [Full Text] [Related]  

  • 22. IP issues facing researchers by Gino D'Oca.
    Almarsson O; Angiolini M; Baell J; Giardina G; Ingham A; Hughes A; Pevarello P; Sindelar R
    Pharm Pat Anal; 2012 May; 1(2):129-35. PubMed ID: 24236778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. US files WTO complaints against Brazil over requirement for "local working" of patents.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2000; 5(4):28. PubMed ID: 11833162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Between pharmaceutical patents and European patients: is a compromise still possible?
    Garattini L; Padula A
    Expert Opin Ther Pat; 2017 Oct; 27(10):1073-1076. PubMed ID: 28671001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patent watch: Drug patenting in India: looking back and looking forward.
    Sampat BN; Shadlen KC
    Nat Rev Drug Discov; 2015 Aug; 14(8):519-20. PubMed ID: 26184492
    [No Abstract]   [Full Text] [Related]  

  • 26. How do public health safeguards in Indian patent law affect pharmaceutical patenting in practice?
    Sampat BN; Amin T
    J Health Polit Policy Law; 2013 Aug; 38(4):735-55. PubMed ID: 23645877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patent watch.
    Harrison C
    Nat Rev Drug Discov; 2013 Jan; 12(1):14-5. PubMed ID: 23274462
    [No Abstract]   [Full Text] [Related]  

  • 28. Herbal drug patenting in India: IP potential.
    Sahoo N; Manchikanti P; Dey SH
    J Ethnopharmacol; 2011 Sep; 137(1):289-97. PubMed ID: 21640810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intellectual property. Balancing innovation and access: patent challenges tip the scales.
    Higgins MJ; Graham SJ
    Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944
    [No Abstract]   [Full Text] [Related]  

  • 30. The political contradictions of incremental innovation: lessons from pharmaceutical patent examination in Brazil.
    Shadlen KC
    Polit Soc; 2011; 39(2):143-74. PubMed ID: 21913365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Legitimate patent extension or patent system abuse?
    Atkinson JD; Moodie RS
    Pharm Pat Anal; 2013 May; 2(3):317-24. PubMed ID: 24237059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introduction: Pharmaceutical firms and the right to health.
    de Campos TC; Pogge T
    J Law Med Ethics; 2012; 40(2):183-7. PubMed ID: 22789038
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug patents and other ways to protect pharmaceutical research].
    Ohana P; Tardieu S; Blin O; Tassy S; Sambuc R
    Therapie; 2004; 59(2):253-7. PubMed ID: 15359623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The strategy of enantiomer patents of drugs.
    Agranat I; Wainschtein SR
    Drug Discov Today; 2010 Mar; 15(5-6):163-70. PubMed ID: 20116449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Panel rules against Canada on patent terms for pre-TRIPS patents.
    Elliott R
    Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):43, 45. PubMed ID: 11833196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A day late and a few million dollars short.
    Goldenson D
    Nat Biotechnol; 2009 Jun; 27(6):538-41. PubMed ID: 19513055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dosing regimens in second medical use patents].
    Suganuma CA
    Cad Saude Publica; 2017 Sep; 33(9):e00096716. PubMed ID: 28977273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patent term extensions: issues, challenges and implications for pharmaceuticals.
    Clark L; Beadle D
    Pharm Pat Anal; 2012 Sep; 1(4):427-35. PubMed ID: 24236881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How are pharmaceutical patent term extensions justified? Australia's evolving scheme.
    Lawson C
    J Law Med; 2013 Dec; 21(2):379-98. PubMed ID: 24597388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analyzing the protection scope limit for biosequence patent claims in China.
    Li W
    Nat Biotechnol; 2018 Sep; 36(9):811-813. PubMed ID: 30188533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.